Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Beer, F. C.
Right arrow Articles by van der Westhuyzen, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Beer, F. C.
Right arrow Articles by van der Westhuyzen, D. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 41, 1849-1857, November 2000
Copyright © 2000 by Lipid Research, Inc.


Original Article

HDL modification by secretory phospholipase A2 promotes scavenger receptor class B type I interaction and accelerates HDL catabolism

Frederick C. de Beera,b, Patrice M. Connella, J. Yua, Maria C. de Beera, Nancy R. Webba, and Deneys R. van der Westhuyzena
a Department of Internal Medicine, University of Kentucky Medical Center, Lexington, KY 40536
b Veterans Affairs Medical Center, Lexington, KY 40511

Correspondence to: Frederick C. de Beer

During inflammatory states plasma levels of high density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apoA-I) are reduced. Secretory group IIa phospholipase A2 (sPLA2) is a cytokine-induced acute-phase enzyme associated with HDL. Transgenic mice overexpressing sPLA2 have reduced HDL levels. Studies were performed to define the mechanism for the HDL reduction in these mice. HDL isolated from sPLA2 transgenic mice have a significantly lower phospholipid content and greater triglyceride content. In autologous clearance studies, 125I-labeled HDL from sPLA2 transgenic mice was catabolized significantly faster than HDL from control mice (4.24 ± 1.16 vs. 2.84 ± 0.1 pools per day, P < 0.008). In both sPLA2 transgenic and control mice, the cholesteryl ester component of HDL was more rapidly catabolized than the protein component, indicating a selective uptake mechanism. In vitro studies using CHO cells transfected with scavenger receptor class B type I (SR-BI) showed that sPLA2-modified HDL was nearly twice as efficient as a substrate for cholesteryl ester transfer. These data were confirmed in in vivo selective uptake experiments using adenoviral vector overexpression of SR-BI. In these studies, increased hepatic selective uptake was associated with increased 125I-labeled apolipoprotein uptake in the kidney.

We conclude that during inflammation sPLA2 hydrolysis of HDL phospholipids alters the lipid composition of the particle, allowing for more efficient SR-BI-mediated selective cholesteryl ester uptake. This enhanced SR-BI activity generates HDL remnants that are preferentially catabolized in the kidney. de Beer, F. C., P. M. Connell, J. Yu, M. C. de Beer, N. R. Webb, and D. R. van der Westhuyzen. HDL modification by secretory phospholipase A2 promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J. Lipid Res. 2000. 41: 1849;–1857.

Supplementary key words: high density lipoprotein, SR-BI, selective cholesteryl ester uptake, adenoviral vector


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
F. C. McGillicuddy, M. de la Llera Moya, C. C. Hinkle, M. R. Joshi, E. H. Chiquoine, J. T. Billheimer, G. H. Rothblat, and M. P. Reilly
Inflammation Impairs Reverse Cholesterol Transport In Vivo
Circulation, March 3, 2009; 119(8): 1135 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jahangiri, M. C. de Beer, V. Noffsinger, L. R. Tannock, C. Ramaiah, N. R. Webb, D. R. van der Westhuyzen, and F. C. de Beer
HDL Remodeling During the Acute Phase Response
Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. J. F. Tietge, N. Nijstad, R. Havinga, J. F. W. Baller, F. H. van der Sluijs, V. W. Bloks, T. Gautier, and F. Kuipers
Secretory phospholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion
J. Lipid Res., March 1, 2008; 49(3): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. C. de Beer and N. R. Webb
Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundant.
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1421 - 1422.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Y. Lee, A. Lesimple, M. Denis, J. Vincent, A. Larsen, O. Mamer, L. Krimbou, J. Genest, and M. Marcil
Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
J. Lipid Res., March 1, 2006; 47(3): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lee, J. M. Timmins, A. Mulya, T. L. Smith, Y. Zhu, E. M. Rubin, J. W. Chisholm, P. L. Colvin, and J. S. Parks
HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney
J. Lipid Res., October 1, 2005; 46(10): 2233 - 2245.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. de Beer, D. van der Westhuyzen, N. L. Whitaker, N. R. Webb, and F. C. de Beer
SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
J. Lipid Res., October 1, 2005; 46(10): 2143 - 2150.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. J. F. Tietge, D. Pratico, T. Ding, C. D. Funk, R. B. Hildebrand, T. Van Berkel, and M. Van Eck
Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress
J. Lipid Res., August 1, 2005; 46(8): 1604 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Boekholdt, T. T. Keller, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, M. S. Sandhu, J. W. Jukema, J. J.P. Kastelein, C. E. Hack, et al.
Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 839 - 846.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. R. Webb, M. C. de Beer, B. F. Asztalos, N. Whitaker, D. R. van der Westhuyzen, and F. C. de Beer
Remodeling of HDL remnants generated by scavenger receptor class B type I
J. Lipid Res., September 1, 2004; 45(9): 1666 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
U. J. F. Tietge, C. Maugeais, W. Cain, and D. J. Rader
Acute inflammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E403 - E411.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Rigotti, H. E. Miettinen, and M. Krieger
The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues
Endocr. Rev., June 1, 2003; 24(3): 357 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Osgood, D. Corella, S. Demissie, L. A. Cupples, P. W. F. Wilson, J. B. Meigs, E. J. Schaefer, O. Coltell, and J. M. Ordovas
Genetic Variation at the Scavenger Receptor Class B Type I Gene Locus Determines Plasma Lipoprotein Concentrations and Particle Size and Interacts with Type 2 Diabetes: The Framingham Study
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2869 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. R. Webb, L. Cai, K. S. Ziemba, J. Yu, M. S. Kindy, D. R. van der Westhuyzen, and F. C. de Beer
The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake
J. Lipid Res., November 1, 2002; 43(11): 1890 - 1898.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. R. Webb, M. C. de Beer, J. Yu, M. S. Kindy, A. Daugherty, D. R. van der Westhuyzen, and F. C. de Beer
Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice
J. Lipid Res., September 1, 2002; 43(9): 1421 - 1428.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. de Beer, D. M. Durbin, L. Cai, N. Mirocha, A. Jonas, N. R. Webb, F. C. de Beer, and D. R. van der Westhuyzen
Apolipoprotein A-II Modulates the Binding and Selective Lipid Uptake of Reconstituted High Density Lipoprotein by Scavenger Receptor BI
J. Biol. Chem., May 4, 2001; 276(19): 15832 - 15839.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement